October 29, 2026For those who have memorized pharmacokinetic terms but get confused by similar options for interactions or ...

A new computational study reports the design and in-silico evaluation of a chimeric antimicrobial peptide fusing LL-37 and ...

ProQR Therapeutics N.V. announced upcoming presentations highlighting clinical and preclinical progress with AX-0810 and ...

L ESCC confirmed ORR of 75% irrespective of PD-L1 status, confirmed ORR of 100% for PD-L1- positive, in evaluable ...

AI-driven protocols, adaptive trials, synthetic control arms and Asia-Pacific expansion can cut costs, reduce screening failures and accelerate oncology studies.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

AI-based platforms improve trial efficiency, recruitment and monitoring, while strategic acquisitions and investments expand real-world evidence capabilities.Dublin, Oct. (GLOBE NEWSWIRE) -- "AI-based ...

The race for global clinical trials is real, and so is our progress. These examples, and many others, show that Canada is ...

United Therapeutics Corporation (NASDAQ:UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin clinical testing of Treprostinil-Iloprost SMI, an investigational inhaled ...

Parexel’s Stacy Hurt draws on her experience with chemotherapy and as a caregiver to spot patient burdens that AI-assisted ...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced that the U.S. Food and Drug Administration ( FDA) has granted clearance under the company’s ...

Appian (Nasdaq: APPN) and PSI CRO announced today the launch of their first joint AI-powered process orchestration solution.

ProQR to present its ADAR-mediated RNA editing approach and progress toward next-generation editing oligonucleotides at TIDES Europe plenary ...